Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00435409 | A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer | completed | Phase 3 | 442 | PfizerINDUSTRY | 18 | Jun 26, 2012 | clinicaltrials |
| NCT00373113 | A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine | terminated | Phase 3 | 482 | PfizerINDUSTRY | 23 | Jun 25, 2012 | clinicaltrials |
| NCT00006459 |
| Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer |
| completed |
| Phase 3 |
| — |
| Eli Lilly and CompanyINDUSTRY |
| 1 |
| Jun 7, 2012 |
| clinicaltrials |
| NCT00241449 | A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer | completed | Phase 3 | 51 | AstraZenecaINDUSTRY | 26 | Jun 6, 2012 | clinicaltrials |
| NCT00849030 | ATAC - Arimidex, Tamoxifen Alone or in Combination | completed | Phase 3 | 9,358 | AstraZenecaINDUSTRY | 0 | Jun 6, 2012 | clinicaltrials |
| NCT00403182 | Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer | withdrawn | Phase 3 | 0 | Technical University of MunichOTHER | 1 | Jun 1, 2012 | clinicaltrials |
| NCT00287040 | Breast Cancer Screening Via Computer V. Phone | completed | Phase 3 | 1,686 | Indiana UniversityOTHER | 1 | May 17, 2012 | clinicaltrials |
| NCT01587248 | Use of Harmonic in Breast Surgery(HMRM) | completed | Phase 3 | 152 | Aga Khan UniversityOTHER | 1 | Apr 30, 2012 | clinicaltrials |
| NCT00171340 | Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. | completed | Phase 3 | 1,065 | Novartis PharmaceuticalsINDUSTRY | 28 | Apr 16, 2012 | clinicaltrials |
| NCT00171314 | The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer | completed | Phase 3 | 527 | Novartis PharmaceuticalsINDUSTRY | 9 | Apr 11, 2012 | clinicaltrials |
| NCT00375427 | Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions | completed | Phase 3 | 430 | Novartis PharmaceuticalsINDUSTRY | 1 | Apr 11, 2012 | clinicaltrials |
| NCT00670878 | Studying the Benefits of Adjuvant Sequential vs. Combined Taxane Based Chemotherapy, Followed by Different Biological Treatment Strategies in Early, HER2-positive Breast Cancer | completed | Phase 3 | 799 | Ludwig-Maximilians - University of MunichOTHER | 1 | Apr 3, 2012 | clinicaltrials |
| NCT00336791 | Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer | completed | Phase 3 | 273 | M.D. Anderson Cancer CenterOTHER | 4 | Feb 14, 2012 | clinicaltrials |
| NCT00243685 | Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis | completed | Phase 2 / Phase 3 | 150 | Pierian BiosciencesINDUSTRY | 1 | Jan 26, 2012 | clinicaltrials |
| NCT00143390 | Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer | completed | Phase 3 | 298 | PfizerINDUSTRY | 1 | Jan 25, 2012 | clinicaltrials |
| NCT00390169 | Randomized Controlled Trial Comparing MBSR to SET in Breast Cancer Patients | unknown | Phase 3 | 300 | Canadian Breast Cancer Research AllianceOTHER | 1 | Jan 19, 2012 | clinicaltrials |
| NCT01508546 | Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast Cancer | completed | Phase 3 | 565 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Jan 12, 2012 | clinicaltrials |
| NCT00002646 | Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer | completed | Phase 3 | 1,500 | Eastern Cooperative Oncology GroupNETWORK | 1 | Jan 5, 2012 | clinicaltrials |
| NCT00245050 | Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer | completed | Phase 3 | 34 | Case Comprehensive Cancer CenterOTHER | 1 | Dec 30, 2011 | clinicaltrials |
| NCT00309556 | Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer | completed | Phase 3 | 536 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Dec 30, 2011 | clinicaltrials |
| NCT01378533 | The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC | unknown | Phase 3 | 100 | Chinese Academy of Medical SciencesOTHER | 1 | Dec 28, 2011 | clinicaltrials |
| NCT00279448 | Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast Cancer(TEAM) | completed | Phase 3 | 9,779 | PfizerINDUSTRY | 1 | Dec 23, 2011 | clinicaltrials |
| NCT00944424 | Phase III Trial of High Dose vs. Standard Dose Vit D2 With Docetaxel in Met Breast ca(GORG-002) | unknown | Phase 3 | 260 | King Faisal Specialist Hospital & Research CenterOTHER | 3 | Dec 13, 2011 | clinicaltrials |
| NCT01479036 | Trial of Neoadjuvant Endostar, Docetaxel and Epirubicin for Patients With Breast Cancer(CBCRT01) | unknown | Phase 3 | 800 | Xijing HospitalOTHER | 1 | Nov 24, 2011 | clinicaltrials |
| NCT00174655 | BIG 02/98 Docetaxel - Breast Cancer | completed | Phase 3 | 2,887 | SanofiINDUSTRY | 21 | Nov 10, 2011 | clinicaltrials |
| NCT00083993 | Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer | terminated | Phase 3 | 1,236 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 2 | Nov 8, 2011 | clinicaltrials |
| NCT01452672 | Resource-sparing Post-mastectomy Radiotherapy in Breast Cancer | unknown | Phase 3 | 600 | International Atomic Energy AgencyOTHER_GOV | 8 | Oct 17, 2011 | clinicaltrials |
| NCT00236899 | Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxanes in MBC | completed | Phase 3 | 241 | Eli Lilly and CompanyINDUSTRY | 1 | Sep 27, 2011 | clinicaltrials |
| NCT00925418 | Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate Cancer(CRYO1) | completed | Phase 3 | 168 | Institut Paoli-CalmettesOTHER | 1 | Sep 14, 2011 | clinicaltrials |
| NCT00712140 | Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer | unknown | Phase 3 | 4,000 | Warwick Medical SchoolOTHER | 1 | Sep 2, 2011 | clinicaltrials |
| NCT00896155 | Trial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer Patients(CONSET) | unknown | Phase 3 | 260 | Tata Memorial HospitalOTHER_GOV | 1 | Aug 30, 2011 | clinicaltrials |
| NCT00376740 | Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving Letrozole | completed | Phase 3 | 90 | Soroka University Medical CenterOTHER | 1 | Aug 23, 2011 | clinicaltrials |
| NCT01415336 | AX Versus AC as Adjuvant Treatment for Node-Negative Breast Cancer | unknown | Phase 2 / Phase 3 | 300 | Peking Union Medical College HospitalOTHER | 1 | Aug 11, 2011 | clinicaltrials |
| NCT01412788 | Safety and Aesthetic Outcomes of Breast Conserving Surgery With Peri-areolar Incision Approach | unknown | Phase 3 | 100 | Peking Union Medical College HospitalOTHER | 1 | Aug 9, 2011 | clinicaltrials |
| NCT00645138 | Comparison of Paravertebral Block With General Anesthesia in Patients Undergoing Breast Cancer Surgery | completed | Phase 3 | 40 | Weill Medical College of Cornell UniversityOTHER | 1 | Aug 5, 2011 | clinicaltrials |
| NCT00152178 | The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC) | completed | Phase 3 | 680 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00152191 | A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC) | completed | Phase 3 | 1,300 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00186212 | Alternative Support for Rural and Isolated Women in an HMO | completed | Phase 3 | 150 | Stanford UniversityOTHER | 1 | Jul 1, 2011 | clinicaltrials |
| NCT00525096 | Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer | completed | Phase 3 | 157 | ARCAGY/ GINECO GROUPOTHER | 0 | Jun 30, 2011 | clinicaltrials |
| NCT00352378 | Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer | completed | Phase 3 | 209 | National Cancer Center, KoreaOTHER_GOV | 0 | Jun 27, 2011 | clinicaltrials |
| NCT00294385 | Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine | completed | Phase 3 | 430 | Central European Cooperative Oncology GroupOTHER | 7 | Jun 23, 2011 | clinicaltrials |
| NCT00942396 | Study to Compare the Diagnostic Accuracy of Nuance Full-Field Digital Mammography to Screen-Film Mammography | withdrawn | Phase 3 | 250 | Planmed OyINDUSTRY | 1 | Jun 9, 2011 | clinicaltrials |
| NCT00246597 | A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer | terminated | Phase 3 | 37 | Ortho Biotech Products, L.P.INDUSTRY | 0 | May 19, 2011 | clinicaltrials |
| NCT00270166 | The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy | completed | Phase 3 | 201 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | May 18, 2011 | clinicaltrials |
| NCT00381901 | Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery | completed | Phase 3 | 3,400 | National Cancer Institute, FranceOTHER_GOV | 1 | May 13, 2011 | clinicaltrials |
| NCT01352091 | Adjuvant AI Combined With Zoladex | unknown | Phase 3 | 670 | Fudan UniversityOTHER | 1 | May 11, 2011 | clinicaltrials |
| NCT01126138 | Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC) | unknown | Phase 3 | 200 | Chinese Academy of Medical SciencesOTHER | 1 | May 4, 2011 | clinicaltrials |
| NCT00193011 | Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer | completed | Phase 3 | 150 | SCRI Development Innovations, LLCOTHER | 0 | May 3, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Jun 26, 2012source: clinicaltrials